2673196-38-6

2673196-38-6 structure

Name: JAK3/BTK-IN-4
Chemical Name: JAK3/BTK-IN-4
CAS Number: 2673196-38-6
Molecular Formula: C₂₁H₂₅ClN₈O
Molecular Weight: 440.93
Catalog: Signaling Pathways Epigenetics JAK
Create Date: 2022-07-01 07:28:57
Modify Date: 2024-01-09 11:26:14
JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-4 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 003)[1]

Name	JAK3/BTK-IN-4

Description	JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-4 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 003)[1]
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
References	[1]. Baoguo Zhang, et al. Pyrimidinopyrimidine and pentacyclic derivatives and their applications. Patent WO2021147953A1.

Molecular Formula	C₂₁H₂₅ClN₈O
Molecular Weight	440.93